KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Net Cash Flow (2016 - 2025)

Evolent Health has reported Net Cash Flow over the past 11 years, most recently at $37.9 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $37.9 million for Q4 2025, down 25.33% from a year ago — trailing twelve months through Dec 2025 was $2.7 million (up 106.0% YoY), and the annual figure for FY2025 was $2.7 million, up 106.0%.
  • Net Cash Flow for Q4 2025 was $37.9 million at Evolent Health, up from -$34.8 million in the prior quarter.
  • Over the last five years, Net Cash Flow for EVH hit a ceiling of $99.3 million in Q1 2025 and a floor of -$99.8 million in Q2 2025.
  • Median Net Cash Flow over the past 5 years was $4.5 million (2023), compared with a mean of -$9.0 million.
  • Biggest five-year swings in Net Cash Flow: crashed 4814.19% in 2021 and later skyrocketed 5063.93% in 2024.
  • Evolent Health's Net Cash Flow stood at $73.2 million in 2021, then crashed by 72.15% to $20.4 million in 2022, then plummeted by 105.02% to -$1.0 million in 2023, then skyrocketed by 5063.93% to $50.8 million in 2024, then dropped by 25.33% to $37.9 million in 2025.
  • The last three reported values for Net Cash Flow were $37.9 million (Q4 2025), -$34.8 million (Q3 2025), and -$99.8 million (Q2 2025) per Business Quant data.